A Pediatrics study
examines the viability of fertility preservation for adolescent and young adult
transgender individuals who have initiated therapy for gender dysphoria. The
study, “Fertility Preservation Outcomes in Adolescent and Young Adult Feminizing Transgender Patients,” to be published in the September 2019 issue
(published online August 5) reviewed data collected retrospectively from 10
patients between 2016 and 2018. Eight of the 10 patients had no prior history
of being treated with gonadotropin-releasing hormones that suppress puberty.
Two patients had previously initiated gonadotropin-releasing hormone and/or
estrogen treatment for gender dysphoria, which they stopped temporarily before
attempting semen cryopreservation. The authors conclude that semen
cryopreservation is a viable method of fertility preservation for feminizing
transgender individuals. Further research is needed to determine the optimal
length of time that gender-affirming therapies should be discontinued for
successful semen cryopreservation.
A solicited commentary, “Fertility Preservation Outcomes and Considerations in Transgender and Gender Diverse Youth,” will be published in Pediatrics.
The American Academy of Pediatrics is an organization of 67,000 primary care pediatricians, pediatric medical subspecialists and pediatric surgical specialists dedicated to the health, safety and well-being of infants, children, adolescents and young adults. For more information, visit www.aap.org and follow us on Twitter @AmerAcadPeds